M. Skala

发表

Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer.

G. Lockwood, T. Rosewall, C. Catton, 2007, International journal of radiation oncology, biology, physics.

Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.

L. Jacks, C. Ménard, R. Bristow, 2012, International journal of radiation oncology, biology, physics.

Development of an International Prostate Cancer Outcomes Registry

D. Roder, M. Skala, N. Nag, 2016, BJU international.

Development of Indicators to Assess Quality of Care for Prostate Cancer.

David P. Smith, D. Roder, M. Frydenberg, 2016, European urology focus.

Urban–rural prostate cancer disparities in a regional state of Australia

J. Dickinson, L. FitzGerald, C. Blizzard, 2022, Scientific reports.

Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New Zealand

L. FitzGerald, A. Hayden, J. Millar, 2021, JAMA network open.

DNA methylation changes following DNA damage in prostate cancer cells

Phillippa C. Taberlay, A. Young, M. Skala, 2019, Epigenetics.

Rhinophyma treated with kilovoltage photons

M. Skala, G. Delaney, Vincent Towell, 2005, The Australasian journal of dermatology.

Analysis of a large prostate cancer family identifies novel and recurrent gene fusion events providing evidence for inherited predisposition

J. Dickinson, L. FitzGerald, A. Banks, 2022, The Prostate.

RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization

J. Dickinson, A. Young, M. Skala, 2014, BMC Cancer.

RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization

J. Dickinson, A. Young, M. Skala, 2014, BMC Cancer.

Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group.

B. Davis, J. Yaxley, A. Hayden, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

FROGG high‐risk prostate cancer workshop: Patterns of practice and literature review

A. Hayden, A. Kneebone, M. Skala, 2014, Journal of medical imaging and radiation oncology.

Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group.

B. Davis, J. Yaxley, A. Hayden, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

Tomas Kron, Andrew Wirth, Benjamin Solomon, 2019, The Lancet. Oncology.

Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial.

S. Vinod, N. Hardcastle, G. Sasso, 2021, JAMA oncology.

Australian & New Zealand Faculty of Radiation Oncology Genito‐Urinary Group: 2010 consensus guidelines for definitive external beam radiotherapy for prostate carcinoma

M. Skala, D. Christie, K. Tai, 2010, Journal of medical imaging and radiation oncology.

Identification of a novel recurrent EEF2 gene amplification in familial prostate tumors

J. Dickinson, L. FitzGerald, L. Blizzard, 2022, Genes, chromosomes & cancer.

Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer.

A. Kneebone, M. Skala, A. Haworth, 2004, Australasian radiology.

Australian & New Zealand Faculty of Radiation Oncology Genito‐Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder

A. Kneebone, J. Millar, F. Foroudi, 2012, Journal of medical imaging and radiation oncology.

MA 13.07 A Randomized Trial of SABR vs Conventional Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: TROG09.02 (CHISEL)

S. Vinod, T. Kron, J. Ruben, 2017 .

The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART.

T. Kron, Colin Tang, F. Foroudi, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

FROGG high‐risk prostate cancer workshop: Patterns of practice and literature review. Part II post‐radical prostatectomy

A. Hayden, A. Kneebone, M. Skala, 2014, Journal of medical imaging and radiation oncology.

Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method.

H. Elsaleh, J. Millar, B. Higgs, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases

S. Vinod, N. Hardcastle, G. Sasso, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

S. Vinod, J. Ruben, L. Irving, 2019, The Lancet. Oncology.